Version 2.78

Description

Barbiturates were first developed in 1864 by Adolf von Baeyer and were widely distributed by the Farbwerke Fr Bayer and Co in 1904. Barbiturates offered new treatment to patients with psychiatric and neurological disorders profoundly improving their prognoses. Barbiturates were also used to treat sleep disorders and were the first drugs to effectively treat epileptic seizures. Due to safety concerns related to drug dependence and overdose and new safer psychoactive medications barbiturate use sharply declined in the 1950s. PMCID: PMC2424120 Secobarbital was first introduce in 1929 by Horace A Shonle and is a barbiturate derivative drug with anesthetic, anticonvulsant, sedative and hypnotic properties. [PubChem: secobarbital] Source: Regenstrief LOINC

Basic Part Properties

Part Display Name
Secobarbital
Part Type
Component (Describes the core component or analyte measured)
Created On
2000-05-04
Construct for LOINC Short Name
Secobarbital

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP16277-3
ConceptMap translate
https://fhir.loinc.org/ConceptMap/$translate?system=http://loinc.org&code=LP16277-3

Language Variants Get Info

Tag Language Translation
zh-CN Chinese (China) 司可巴比妥
Synonyms: C12H18N2O3;速可眠
fr-CA French (Canada) Sécobarbital
et-EE Estonian (Estonia) Sekobarbitaal
es-ES Spanish (Spain) Secobarbital
it-IT Italian (Italy) Secobarbital
tr-TR Turkish (Turkey) Sekobarbital
ru-RU Russian (Russian Federation) Секобарбитал
nl-NL Dutch (Netherlands) secobarbital
fr-BE French (Belgium) Sécobarbital